Announcement

Collapse
No announcement yet.

InVivo Therapeutics Receives Prestigious 2011 Apple Award for Top Publication in Brea

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • InVivo Therapeutics Receives Prestigious 2011 Apple Award for Top Publication in Brea

    InVivo Therapeutics Receives Prestigious 2011 Apple Award for Top Publication in Breakthrough Spinal Cord Injury Research

    InVivo Therapeutics (OTCBB: NVIV), a company focused on the development of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today announced that Chief Science Officer Dr. Christopher Pritchard, Ph.D., has been selected as the 2011 recipient of the American Spinal Injury Association’s (ASIA) prestigious Apple Award. The award recognizes excellence in publishing in spinal cord injury research across the globe.

    Dr. Pritchard and his InVivo Therapeutics team authored the article titled: “Establishing a model spinal cord injury in the African green monkey for the preclinical evaluation of biodegradable polymer scaffolds seeded with human neural stem cells.” The article was published in 2010 in the Journal of Neuroscience Methods (188, 258-269). Co-authors are Jonathan R. Slotkin, Dou Yu, Haining Dai, Matthew S. Lawrence, Roderick T. Bronson, Francis M. Reynolds, Yang D. Teng, Eric J. Woodard, and Robert S. Langer.

    read...

    http://www.bradenton.com/2011/04/29/...estigious.html

  • #2
    awesome
    Donnie: Dr. Xiao, What are your thoughts on a cure/combination therapy for SCI's??
    CG Xiao: Donnie, I don't want to disappoint you, but I think it is impossible to restore the continuity of the cord or "bridge the gap" in the near future, let's say: 50 years. Dr Wise Young has been my most respected scientist in SCI. He has dedicated and contributed to SCI no other can match.

    Comment


    • #3
      Originally posted by Donnie View Post
      awesome
      dr xiao, bullshit!

      Comment


      • #4
        Originally posted by manouli View Post
        InVivo Therapeutics Receives Prestigious 2011 Apple Award for Top Publication in Breakthrough Spinal Cord Injury Research

        InVivo Therapeutics (OTCBB: NVIV), the 2011 recipient of the American Spinal Injury Association’s (ASIA) prestigious Apple Award. The award recognizes excellence in publishing in spinal cord injury research across the globe.
        The award is NOT for his scaffolding but rather for publishing excellence.

        Comment

        Working...
        X